CDK19 and prostate carcinoma: For instance, the m6A modification of the NEAT1 lncRNA promoted the bone metastasis of prostate cancer by facilitating the CYCLINL1-CDK19 interaction, which was required for the ser2 phosphorylation of Pol II (34).